SLU-PP-332 Capsules

Description

SLU-PP-332 is a small-molecule compound examined in vitro for its activity as a PPARδ/β agonist, with potential relevance in metabolic and performance-oriented research. Preliminary investigations have evaluated its influence on endurance, lipid utilization, mitochondrial efficiency, and overall energy output.

This oral capsule formulation provides 1 mg per capsule and is packaged in a 60-count bottle to support consistent dosing in extended laboratory research protocols.

Specifications

• Dosage Form: Oral capsule (1 mg per capsule)
• Bottle Size: 60 capsules
• Compound Type: Investigational PPARδ/β agonist
• Molecular Weight: Approximate value; varies based on small-molecule structure
• Storage: Keep tightly sealed in a cool, dry environment (2°C–8°C). Protect from heat, light, and moisture.

Application Context

SLU-PP-332 is studied in vitro for its potential involvement in:

• Mitochondrial biogenesis and cellular energy metabolism
• Fatty acid oxidation and endurance-associated pathways
• Skeletal muscle adaptation and performance models
• Glucose regulation and metabolic function research
• Cellular signaling through PPARδ/β receptor activation

Intended Use

This product is intended strictly for in vitro laboratory research purposes only. It is not approved for use in humans or animals and must not be used in food, supplements, pharmaceuticals, or cosmetic products.

Legal Disclaimer

This product and the accompanying information have not been evaluated by the U.S. Food and Drug Administration. No claims are made regarding the diagnosis, treatment, cure, or prevention of any disease or condition. Use is restricted to qualified professionals operating in certified research environments.

Terms of Sale

By purchasing from Midwest Peptide, the buyer confirms they are a qualified researcher or institution and accepts full responsibility for proper handling, storage, and compliance with all applicable regulations. All sales are final.